Hisun Pharmaceutical’s non-public issuance results released

Business News March 17 hearing Hisun Pharmaceutical announced on the 17th, the company's non-public issuance has settled, the final issue price is determined as 33.28 yuan / share, relative to the issue price of 22.53 yuan / share premium 47.71%, a total of 5 specific The targets were purchased: 15 million shares of China Life Insurance Asset Management Co., Ltd., 12 million shares of Shanghai Yiyi Industrial Co., Ltd., 5 million shares of Cinda ADB Fund Management Co., Ltd., 5 million shares of Youngor Group Co., Ltd. and Shenzhen Ping An. 40,822,000 shares of Innovation Capital Investment Co., Ltd.